Christine Desrochers - ConforMIS Co Controller
| CFMSDelisted Stock | USD 2.23 0.01 0.45% |
Insider
Christine Desrochers is Co Controller of ConforMIS
| Phone | 781 345 9001 |
| Web | https://www.conformis.com |
ConforMIS Management Efficiency
The company has return on total asset (ROA) of (0.2732) % which means that it has lost $0.2732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7871) %, meaning that it created substantial loss on money invested by shareholders. ConforMIS's management efficiency ratios could be used to measure how well ConforMIS manages its routine affairs as well as how well it operates its assets and liabilities.ConforMIS currently holds 27.5 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. ConforMIS has a current ratio of 5.6, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ConforMIS's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Todd Huntsman | Vivos Therapeutics | N/A | |
| William MD | Nuwellis | N/A | |
| Dennis Maier | Artivion | 50 | |
| Jesse Selnick | Sight Sciences | N/A | |
| Lawrence Mertz | Accelerate Diagnostics | 61 | |
| Blake Gurfein | Tivic Health Systems | 40 | |
| Joshua Wells | Artivion | N/A | |
| Ehab Esmail | Orthofix Medical | 52 | |
| Jonathan Paris | Rapid Micro Biosystems | 48 | |
| Jean Holloway | Artivion | 63 | |
| Sandra Eayrs | Nuwellis | N/A | |
| Matthew Getz | Artivion | 55 | |
| Andre Marquette | Neuropace | N/A | |
| Mark MD | Bluejay Diagnostics | N/A | |
| Anne Nunes | Anika Therapeutics | 54 | |
| Gregory Davault | Axogen Inc | 56 | |
| Jonathan Rothberg | Hyperfine | 60 | |
| Rebecca Kuhn | Neuropace | 63 | |
| Laura Pierson | Accelerate Diagnostics | N/A | |
| Mark Hughes | Hyperfine | 61 | |
| John Davis | Artivion | 59 | |
Management Performance
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 |
ConforMIS Leadership Team
Elected by the shareholders, the ConforMIS's board of directors comprises two types of representatives: ConforMIS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConforMIS. The board's role is to monitor ConforMIS's management team and ensure that shareholders' interests are well served. ConforMIS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConforMIS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Howe, CFO Treasurer | ||
| Michael Fillion, Chief Officer | ||
| Erin Henry, Co Controller | ||
| MPH JD, Chief Sec | ||
| Farzin Khaghani, VP Marketing | ||
| Christine Desrochers, Co Controller | ||
| Mark Augusti, President CEO, Director | ||
| Allison Baker, Director HR | ||
| Eric Rickenbach, VP Sales | ||
| Terrance Wong, VP Regulatory |
ConforMIS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ConforMIS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.71) % | |||
| Current Valuation | 18.21 M | |||
| Shares Outstanding | 7.88 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 22.50 % | |||
| Number Of Shares Shorted | 83.58 K | |||
| Price To Earning | 5.96 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in ConforMIS Stock
If you are still planning to invest in ConforMIS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ConforMIS's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |